Call for Life: Exploring mHealth Solutions for Enhancing Childhood Vaccinations Among Displaced Children in Conflict-affected Settings of Nigeria

NCT ID: NCT07154836

Last Updated: 2025-09-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Clinical Phase

NA

Total Enrollment

366 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-24

Study Completion Date

2025-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates the feasibility and preliminary impact of Call for Life, an mHealth platform aimed at increasing childhood vaccination coverage among internally displaced persons in Borno State, Nigeria. The platform uses an interactive voice response (IVR) system to deliver automated vaccination reminders, follow up on reported side effects, and provide health messages in English and local languages. A mixed-methods design is used to assess feasibility, interaction rates, and early effects on vaccine uptake. Findings will inform policymakers and humanitarian actors on the potential of mobile technology to strengthen immunization delivery in conflict-affected, resource-limited settings.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Access to Immunization

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Call4life

Care givers will be reminded using telephone calls to go vaccine their children

Group Type EXPERIMENTAL

Telephone calls

Intervention Type OTHER

Regular telephone reminders and health information will be sent to help mothers or caregivers of children 0-23 months to remind them to go vaccine their children

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Telephone calls

Regular telephone reminders and health information will be sent to help mothers or caregivers of children 0-23 months to remind them to go vaccine their children

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Call4life

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* • Caregivers (male/female) of children from 0-23 months of age or pregnant women in third trimester

* Caregivers above the age of 18 years of age
* Caregivers who consent to participate in the study.
* Resident in the IDP camp for at least one year

Exclusion Criteria

* • Pregnant women in third trimester in first pregnancy (primigravida)

* Caregivers that are temporary residents of the IDP camps (IDPs on transit or visitors)
* Caregivers without the mental capacity to comprehend the questions asked.
* Inability to use or interact with a mobile phone ( e.g. those with hearing defects or poor vision)
Minimum Eligible Age

23 Months

Maximum Eligible Age

23 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Maiduguri

OTHER

Sponsor Role collaborator

Infectious Disease Institute at Makerere University

UNKNOWN

Sponsor Role collaborator

University of Cambridge

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lundi-Anne Omam Ngo Bibaa

Dr

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

El Miskin

Jere, Borno State, Nigeria

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Nigeria

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Not application

Identifier Type: OTHER

Identifier Source: secondary_id

Call-4-Life

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Measles Vaccination at Health System Contacts
NCT04220671 ENROLLING_BY_INVITATION PHASE4